Professor of Department of Biological Science, Sungkyunkwan University, Suwon, Korea. Dr. Kim serves as an editor of Journal of Glycobiology, eCAM, Peer Journal (2012-), Glycobiology Insights, Int J Mol Sci, Front. Pharm, Curr Pharm Biotehcnol  and eCAM. He also served as International Scientific Advisory Board Member, International Symposium for Glycosyltransferases (GlycoT 2006), IUBMB symposium, Tsukuba and GlycoT 2008, Emory University, GA, USA, and International Biochemical and Molecular Engineering 2013 (San Antonio, TX, USA). He is the author of over 300 peer-reviewed articles published in national and international scientific journals. His distinguished discoveries recognized in the biomedical area are well documented in the Academic Society from the following outstanding findings: Viral carcinoma and PTEN (Cancer Research 2003), UDP-N-GlcNAc:β-D-Man-1,4-N-GlcNAc-T-III in hepatitis (Glycoconj J 2003), plasma MMP-9/2 and α-fetoproteins (J Gastroenterol. Hepat. 2004), HBx metastatic potential (FASEB J. 2004), GnT-III-Apolipoprotein B (JBC. 2004), Disialo GD3 in VSMC responses (JBC. 2004), Therapeutic hepatocarcinoma cells (FASEB J. 2004), Transglutaminase 2 in leukemia (FEBS Lett. 2004), bisecting N-GlcNAc-III(J Gastroenterol Hepatol, 2004), GM3 in leukemic differentiation (Glycobiology 2005), MMP-9 in IVF (Br J Obstetr Gynecol, 2005), GD3 Fas-induced T cells (Glycobiology 2006), GM3 in PTEN-mediated progression (Glycobiology 2006), Vascular ROS in GD3-cell function (FASEB J 2006), AP-2a in GM3-PTEN (Glycobiology 2008), sialidase in leukemia (BBA, 2008), GM3-VEGFR-2 interqaction (Glycobiology 2009), GD3 in cancer (Biol Chem. 2009), pig CMAH and N-glycolylneuraminic acid (Biochemical J 2010), pST6GalNAc IV for Neu5Acalpha2-3Galbeta1-3GalNAc (Glycoconj J 2011), GM3 in TGF-β1-induced EMT (Biochem J 2013), VEGFR-2 in neovascularization (JMM 2013). GD3/α1-adrenergic receptor/transglutaminase 2 in erythroid differentiation in CML(Oncotarget 2017). Sirt1-FcεRI-mediated mast cell activation through AMPK- and PTP1B (Scientific Report 2017). His pioneered findings on Glycan and carbohydrate interaction for the diseases-preventiveand treating drugs are filed in US patents.